Advertisement

Hope on the Horizon: Ushering in the New Era in the Management of Vitiligo

Global Vitiligo Foundation President Seemal Desai, MD, Associate Professor of Clinical Dermatology at the University of Texas-Southwestern in Dallas, TX, and Pearl E. Grimes, MD, Director of the Vitiligo and Pigmentation Institute of Southern California in Los Angeles, CA, have devoted much of their careers to treating vitiligo. They discuss the revolution and evolution of vitiligo treatment, which was spurred by the approval of topical ruxolitinib (Opzelura, Incyte) and is bolstered by a robust pipeline.
Keeping the Color: Maintenance Strategies After Vitiligo Repigmentation
The Evolution of Vitiligo Treatment: From Steroids and Broad Immunosuppression to Targeted JAK Inhibition
Of Patients and Patience in Vitiligo: The Importance of Managing Treatment Expectations
A Deep Dive Into Vitiligo and Its Associated Comorbidities
It’s a Marathon, Not a Sprint: Achieving Repigmentation in Vitiligo With Topical JAK Inhibitors
Advertisement

About This Educational Video Series

This educational video series provides expert commentary on the current treatment landscape for patients with vitiligo.